1 / 8

Bioreactors Market Growth Analysis & Forecast Report | 2021-2027

The demand for cancer therapeutic drugs is rising exponentially. Growing cases of cancer has influenced the development of bioprocessing equipment, adoption of advanced technologies, and increasing demand for single-use bioreactors for developing effective cancer treatments. Rising investments in research and development programs by governments and major players may augment the revenue strides of bioreactors market.

sudeepkedar77
Download Presentation

Bioreactors Market Growth Analysis & Forecast Report | 2021-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bioreactors Market Opportunities, Top Key Player and Forecast To 2027

  2. Industry Insights: • The bioreactors market is expected to expand on the back of rising requirement for improved pharmaceuticals, vaccines, and antibodies worldwide. The COVID-19 pandemic has impacted millions of lives across the globe. Surge in casualties caused by the pandemic has sparked an increase in demand for vaccines and other biologics to control the spread of the virus. • To meet the global demand for COVID-19 vaccines, biopharmaceutical companies are spearheading research and development (R&D) activities, generating record demand for bioreactors. Recently, the Serum Institute of India was said to incorporate six 4,000L CSR bioreactors for mass producing Novavax’s COVID-19 vaccine candidate

  3. Major players operating in the global bioreactors industry include Sartorius Stedim Biotech Group, Cytiva, Eppendorf, and Merck Group among other players. Strategic initiatives like mergers, acquisitions, and new product launches, are some of the approaches taken by bioreactor manufacturers to hold and maintain their position in the market. • Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/141 • Highlighting an instance, in January 2020, Getinge completed the acquisition of Applikon Biotechnology B.V., a company involved in manufacturing and supply of advanced bioreactors for R&D in biopharmaceutical companies. The strategy was slated to strengthen the firm’s life sciences business with portfolio expansion.

  4. Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/bioreactor-market Chapter 4 Bioreactors Market, By Product Type 4.1 Key segment trends 4.2 Single-use 4.2.1 Market size, by region, 2016-2027 (USD Million) 4.3 Reusable 4.3.1 Market size, by region, 2016-2027 (USD Million)

  5. Chapter 5 Bioreactors Market, By Cell 5.1 Key segment trends 5.2 Mammalian cells 5.2.1 Market size, by region, 2016-2027 (USD Million) 5.3 Bacterial cells 5.3.1 Market size, by region, 2016-2027 (USD Million) 5.4 Yeast cells 5.4.1 Market size, by region, 2016-2027 (USD Million) 5.5 Others 5.5.1 Market size, by region, 2016-2027 (USD Million)

  6. Region: • The Asia Pacific region is expected to witness lucrative demand for bioreactors in the estimated timeframe. Presence of firms with robust manufacturing capacity in the healthcare sector and advancements in hi-tech technology may support promising developments in the bioreactors market. • As per a report, the Asia Pacific constituted to around 20% of the global bioreactors market share in 2020. The region offers multiple opportunities to national and international pharmaceutical companies for collaborations, innovative and product development with the government initiatives and investments in healthcare and R&D offering needed support.

  7. Key Players • Merck Group • Danaher Corporation • PBS Biotech • Pierre Guerin Sas (Engie) • Sartorius Stedim Biotech Group • Shanghai Bailun Biotechnology Co. Ltd. • Solaris Biotech Solutions • Thermo Fisher Scientific

  8. Stay In Touch Social Media:

More Related